Treatment Guidelines for Neonatal Narcotic Abstinence Syndrome with Diluted Oral Morphine and Clonidine
|
|
- Horatio Austin
- 8 years ago
- Views:
Transcription
1 Treatment Guidelines for Neonatal Narcotic Abstinence Syndrome with Diluted Oral Morphine and Clonidine Background Morphine sulfate has been recommended by the AAP as the first-line agent for the pharmacologic treatment for neonatal narcotic abstinence syndrome (NNAS). Clonidine has been widely used as a non-opioid alternative for managing opioid withdrawal in adults. A recent study (Agthe et al, Pediatrics 2009) comparing Morphine with a combination of Morphine and Clonidine for the treatment of NNAS demonstrated shorter duration of therapy, lower Morphine doses, and shorter hospital stays for infants receiving combination therapy. Clonidine use has been shown to be associated with a clinically-insignificant lowering of the heart rate (5bpm) and blood pressure (5mmHg). No other adverse effects were noted. Management The pharmaceutical treatment should be used in combination with supportive measures including: swaddling, holding, decreasing environmental stimuli, pacifiers, and rocking. A. INITIATION 1. Begin NNAS scoring every 4-6 hrs (every other feeding). 2. Initiate combination therapy with oral Morphine and Clonidine for three consecutive withdrawal scores are 8 or any one time score is 12 using the Neonatal Withdrawal Inventory (NWI) scale. 3. Initial doses: a. Morphine at 0.05 mg/kg/dose PO every 3 hours with feedings. b. Clonidine at 0.75 mcg/kg/dose every 3 hours (rounded to nearest 0.1mcg) 4. Increase Morphine dose by 0.01mg/kg/dose every 12 hours until withdrawal symptoms are controlled (two consecutive NWI scores <8). Morphine dosing should be titrated to the desired effect, with a usual maximum dose of 0.2 mg/kg every 3 hours. 5. Adjust Clonidine dose to weight weekly to maintain daily dose of 6mcg/kg/day. 6. If maximum dose for Morphine is reached (0.2 mg/kg/dose): Consider adding Phenobarbital (loading dose 20mg/kg in two divided dose of 10mg/kg every 12 hours), followed by a maintenance dose of 5mg/kg/day once
2 daily. Clonidine should be discontinued 24 hours after completion of the Phenobarbital loading dose. B. WEANING 1. Weaning should begin after NNAS symptoms are controlled for 48 hrs (total NWI score 24 over three consecutive measurements). 2. Begin weaning Morphine by 0.04mg (flat dose) or by 10% of the highest dose, whichever is greater. Weaning can be done every day provided that the NWI scores are stable during weaning. If two scores in a 24-hour period are 8, consider increasing the dose back to the previous effective dose. 3. Morphine may be discontinued from a dose of 0.06mg (flat dose). 4. After 24 hours off Morphine, the Clonidine may be decreased by 50%. If NWI scores remain stable for 12 hours, the Clonidine may be discontinued. If total NWI scores exceed 24 over the next three measurements after stopping Clonidine, restart Morphine at 0.04mg every 3-4 hours with feeding. 5. Patient may be discharged if NWI scores remain stable (total NWI Score 24 over three consecutive measurements for 1-2 days) off medication and the following criteria are met - a. Infant is taking oral feeds and gaining weight b. All newborn assessments/procedures have been completed (Hepatitis B Vaccination, hearing screening test, State Screening Tests) c. Social work has cleared the infant and a suitable home is arranged d. VNA is set up if deemed necessary e. Follow-up with the PMD is arranged C. BP MONITORING 1. Monitor BP per unit protocol (at least q shift) for the first 48 hours after starting Clonidine. If blood pressure remains stable, continue BP measurements every 12 hours during treatment. 2. Monitor BP per unit protocol (at least q shift) when discontinuing Clonidine and for the first 24 hours off Clonidine.
3 References 1. AAP Committee on Drugs. Neonatal Drug Withdrawal. Pediatrics 1998; 101: Agthe AG, et al. Clonidine as an Adjunct Therapy to Opioids for Neonatal 3. Abstinence Syndrome: A Randomized, Controlled Trial. Pediatrics May;123(5):e Epub 2009 Apr Opiate Treatment for Opiate Withdrawal in Newborn Infants Cochrane Review. 5. Zahorodny W, Rom C, Whitney W, Giddens S, Samuel M, Maichuk G, Marshall R. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. J Dev Behav Pediatr Apr;19(2): Reviewed by Yogangi Malhotra, MD, Dael Nelson, PAC, David Cheromcha, MD, Richard Ehrenkranz, MD, Matthew Grossman, MD, Barbara Sabo, APRN
4 NEONATAL WITHDRAWAL INVENTORY SCALE Hypertonia 2 Regurgitaion/Vomiting 2 Loose,watery stool 2 Sneezing or yawning 1 Sweating or mottling 2 Hyperactive Moro Reflex 2 Tremors when disturbed OR 3 Tremors undisturbed 4 Irritability OR 1 Crying or frantic fist sucking OR 2 Excoriation OR 3 Continuous Crying (restless even after intervention) 4 TOTAL Score # 1 # 2 # 3 # 4 # 1 # 2 # 3 # 4 # 1 # 2 # 3 # 4 # 1 # 2 # 3 # 4 # 1 # 2 # 3 # 4 Morphine Dose Clonidine Dose Other: Dose Other: Dose Temperature Respiratory Rate DATE: TIME: INITIALS: mg/kg mcg/kg /kg /kg celcius
5 NEONATAL WITHDRAWAL INVENTORY SCALE HELPFUL HINTS: STEPS IN SCORING Conduct scoring within one hour prior to every other feeding (a 6 hour caregiving interval). If NPO conduct scoring every 6 hours. Observe infant without disturbing the infant for 1 minute. Encourage the baby to a quiet awake state. Take note of the infant's ability to transition states smoothly. While in quiet awake state, assess moro reflex, measure axillary temperature, inspect skin for signs of excoriation and change diaper.. Following your observations, score the infant using the neonatal withdrawal inventory criteria. HYPERTONIA SCORING FYIs Score for increased tone that may interfere with suck swallow coordination as compared with a non-withdrawing newborn of comparable gestation and condition. For the intubated or NPO infant, this section should assess the infant's muscle tone as compared to the non-withdrawing newborn of comparable gestation and condition. REGURGIATION Score for true emesis of formula/bm seen in the mouth not associated with burping following a feeding. For the intubated who is feeding score for true emesis seen following a gavage feeding or for an aspirate prior to the feeding greater than 1/3 of the previous feeding For NPO infants, only score if infant has large aspirate or is vomiting. LOOSE, WATERY STOOLS Stools are minimally formed or no solid stool noted. Often you will see a water ring in the diaper. SNEEZING OR YAWNING Score if the baby sneezes or yawns at least 6-8 times in the 6 hour time frame. SWEATING OR MOTTLING Score if you see sweating on the upper lip or forehead. Ensure the infant is not over bundled and the isolette is not overheated. Score for mottling not associated with hypothermia/cold stress (axillary temp < 36.0). HYPERACTIVE MORO RELEEX A moro reflex is expected... Score infant if an exaggerated moro response is exhibited compared to the non-withdrawing newborn of comparable gestation and condition. For the intubated infant do a modified moro. TREMORS Tremors are high frequency, low amplitude "shaking" of the arms and/or legs. If tremors are only present when disturbed such as after a physical exam, unbundling, taking vital, etc. then score as 3. If the tremors are present without any stimulation, then score a 4. BEHAVIOR Choose the one description which describes the baby ANY TIME during the 6 hour scoring interval. Irritable: remains restless even after feeding or other intervention to calm infant such as swaddling, rocking,offering pacifier, kangaroo care. Crying or frantic fist sucking Fresh excorioation of chin, face, knees or elbows. This means the baby is so irritable he/she is rubbing the face or extremities on the bedding, causin excoriation of the points of contact. Do not score for a diaper rash. Continuous crying and an inability to sleep or feed dispite all interventions for calming the baby.
Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -2/11/13
Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -// What is Neonatal Abstinence Syndrome? Neonatal withdrawal after intrauterine exposure
More informationChallenges of Foster Parents who Care for Infants with Neonatal Abstinence Syndrome
Challenges of Foster Parents who Care for Infants with Neonatal Abstinence Syndrome All Health Care Providers are required by law to make a referral to the Department of Children s Services (DCS) Child
More informationSubstance Use Guideline 4B PERINATAL OPIOID EXPOSURE, CARE OF THE NEWBORN
British Columbia Reproductive Care Program Substance Use Guideline 4B PERINATAL OPIOID EXPOSURE, CARE OF THE NEWBORN INTRODUCTION During the antenatal period, the opportunity exists for the primary care
More informationWales Neonatal Network Guideline
Guideline on the Management of Neonatal Abstinence Syndrome Introduction Neonatal Abstinence Syndrome (NAS) is a constellation of symptoms and signs occurring in a baby as a result of withdrawal from physically
More informationNeonatal Abstinence Syndrome (NAS)
Women and Newborn Health Service King Edward Memorial Hospital Neonatal Abstinence Syndrome (NAS) W O M E N A N D N E W B O R N drug and alcohol service (wandas) Delivering a Healthy WA Neonatal Abstinence
More informationNEONATAL ABSTINENCE SYNDROME. Osama Naga, M.D. PGY2
NEONATAL ABSTINENCE SYNDROME Osama Naga, M.D. PGY2 Objective: Describe the common causes of NAS Clinical Presentation Diagnosis Identify the different scoring system for pharmacologic therapy Minimize
More informationNEONATAL ABSTINENCE SYNDROME AND SCORING SYSTEM
VIDANT MEDICAL CENTER PATIENT CARE _ SUBJECT: Abstinence Scoring NUMBER: A-1 PAGE: 1 OF: 5 _ NEONATAL ABSTINENCE SYNDROME AND SCORING SYSTEM POLICY: A thorough evaluation of the infant is required in order
More informationCHILDREN S SERVICES. Neonatal Abstinence Syndrome
CHILDREN S SERVICES Neonatal Abstinence Syndrome Background Neonatal Abstinence Syndrome (NAS) is a combination of behavioural and physiological signs and symptoms that occur in newborns going through
More informationManagement of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal
Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal Kirsten H. Ohler, Pharm.D., BCPS Clinical Assistant Professor Neonatal / Pediatric Clinical Pharmacist University of Illinois at
More informationNeonatal Abstinence Syndrome. A Guide for Families
Neonatal Abstinence Syndrome A Guide for Families Contents What is Neonatal Abstinence Syndrome (NAS)?...................... 4 When will my baby show signs of NAS?..................................................
More informationCurrent Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010 Substance Exposed Newborns Alcohol Tobacco Caffeine Amphetamines Cocaine Barbituates Selective Serotonin Re-uptake
More information(peak at 2 days 6 wks)
Perinatal Manual of Southwestern Ontario A collaboration between the Regional Perinatal Outreach Program of Southwestern Ontario & the Southwestern Ontario Perinatal Partnership (SWOPP) Chapter 46 NEONATAL
More informationEvaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients
Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Jennifer Kuhns, Pharm.D. Pharmacy Practice Resident Children s Hospital of Michigan **The speaker has no actual or potential
More informationA guide for parents of babies at risk of Neonatal Abstinence Syndrome Planning care for you and your baby
A guide for parents of babies at risk of Neonatal Abstinence Syndrome Planning care for you and your baby Reading this booklet can help you: learn how certain drugs can affect your baby during pregnancy
More informationNNEPQIN Guideline for the Management of Labor, Delivery and the Newborn in the Opioid Dependent Pregnancy. March 2014
The following guidelines are intended only as a general educational resource for hospitals and clinicians, and are not intended to reflect or establish a standard of care or to replace individual clinician
More information2013 Transforming Neonatal Drug Withdrawal
2013 Transforming Neonatal Drug Withdrawal Carl R. Backes, DO Director, Neonatal Abstinence Clinic Nationwide Children s Hospital Clinical Assistant Professor, The Ohio State University How Big is the
More informationSOUTH CENTRAL NEONATAL NETWORK GUIDELINE. South Central (North) Guideline for Neonatal Drug Withdrawal
SOUTH CENTRAL NEONATAL NETWORK GUIDELINE South Central (North) Guideline for Neonatal Drug Withdrawal Approved by & South Central Neonatal Steering Group for South Central North. date Date of Implementation
More informationNHS FORTH VALLEY Management of Neonatal Abstinence Syndrome
NHS FORTH VALLEY Management of Neonatal Abstinence Syndrome Date of First Issue 25/10/2011 Approved 25/11/2011 Current Issue Date 30/11/2011 Review Date 30/11/2013 Version 1.00 EQIA Yes 06/12/2011 Author
More information4/28/2014. Care of the Opiate Exposed Newborn and Family Marybeth Tyler, NNP-BC, MS, IBCLC May, 2014. The reality: Poly drug exposure
Practice Gap: Need for increased education regarding management of Neonatal Abstinence Syndrome Desired Outcome: Increased awareness and understanding of NAS Care of the Opiate Exposed Newborn and Family
More informationWITHDRAWAL OF ANALGESIA AND SEDATION
WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses
More informationInformation Booklet for Mum and Baby
WOMEN AND NEWBORN HEALTH SERVICE King Edward Memorial Hospital Information Booklet for Mum and Baby Women and Newborn Drug and Alcohol Service (WANDAS) Delivering a Healthy WA This booklet is designed
More information4/18/14. Background. Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients. Background. Signs and Symptoms of Withdrawal
Background 1 Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Alyssa Cavanaugh, PharmD PGY1 Pharmacy Resident Children s Hospital of Michigan **The speaker has no actual or
More informationOFF TO A GOOD START: #9 Caring For the Drug Affected Infant
OFF TO A GOOD START: #9 Caring For the Drug Affected Infant 1.0 Hour Training Credit Published by Alaska Center for Resource Families 1-800-478-7307 Funded by the State of Alaska Office of Children s Services
More informationIntroduction to Neonatal Abstinence Syndrome
Introduction to Neonatal Abstinence Syndrome Cara Christ, MD Director, Arizona Department of Health Services Learning Objectives 1.Define Neonatal Abstinence Syndrome 2.Describe Neonatal Abstinence Syndrome
More informationBABIES BORN TO ADDICTED MOTHERS
BABIES BORN TO ADDICTED MOTHERS PATRICA M. MESSERLE LICENSED CLINICAL PSYCHOLOGIST, M.A., ABSNP LICENSED SCHOOL PSYCHOLOGIST DIPLOMATE OF THE AMERICAN BOARD OF SCHOOL- NEUROPSYCHOLOGY 1 Signs and Symptoms
More informationNEONATAL ABSTINENCE SYNDROME (NAS)- THE CARE YOUR BABY MAY NEED
NEONATAL ABSTINENCE SYNDROME (NAS)- THE CARE YOUR BABY MAY NEED Information Leaflet Your Health. Our Priority. Page 2 of 8 Welcome to Stepping Hill Hospital Women's Unit The aims of this leaflet are to:
More informationWhat is Methadone? Opioid Treatment Programs Today. Is Methadone Safe? Pain Clinics. Wisconsin OTPs. Methadone Maintenance Treatment 5/6/2013
Methadone Maintenance Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority April 22, 2013 What is Methadone? Schedule II pharmaceutical opioid similar to Oxycodone or morphine. Binds to the
More informationChildren s Specialized Hospital Neonatal Abstinence Syndrome (NAS)
Children s Specialized Hospital Neonatal Abstinence Syndrome (NAS) A Pharmacologic and Rehabilitation Program that Promotes Narcotic Weaning and Autonomic Regulation Necessary for Infant Development Sharon
More informationNeonatal Abstinence Syndrome: Indian Health Service (IHS) Best Practices Guidelines
Neonatal Abstinence Syndrome: Indian Health Service (IHS) Best Practices Guidelines 1. Neonatal Drug Withdrawal Intrauterine exposure to certain drugs and medications can cause clinical symptoms in the
More informationNeonatal Abstinence Syndrome
Neonatal Abstinence Syndrome D COGHLAN, *M MILNER, T CLARKE, I LAMBERT, C MCDERMOT, M MCNALLY, M BECKETT. T MATTHEWS Department of Paediatrics and *Obstetrics. Rotunda Hospital. Parnell Square. Dublin
More informationPrevention and Treatment of Opioid and Benzodiazepine Withdrawal
1.0 Introduction The purpose of this guideline is to ensure that patients who are at risk of developing withdrawal symptoms can be weaned off opioids and benzodiazepines in a timely fashion. It is appropriate
More informationUniversity of Michigan Alcohol Withdrawal Guidelines Overview
University of Michigan Alcohol Withdrawal Guidelines Overview The following document contains the University of Michigan Alcohol Withdrawal Guidelines. These guidelines were developed through an intensive
More informationNeonatal Abstinence Syndrome Anthony E. Burgos and Bryan L. Burke, Jr. DOI: 10.1542/neo.10-5-e222
Neonatal Abstinence Syndrome Anthony E. Burgos and Bryan L. Burke, Jr NeoReviews 2009;10;e222-e229 DOI: 10.1542/neo.10-5-e222 The online version of this article, along with updated information and services,
More informationEthical Issues Related to Long-Term Consequences of Neonatal Abstinence Syndrome (NAS) Christopher Church, Ph.D.
Ethical Issues Related to Long-Term Consequences of Neonatal Abstinence Syndrome (NAS) Christopher Church, Ph.D. Content and Objectives Content: Describe common ethical issues related to caring for babies
More informationMedical Center of Central Georgia Neonatal Intensive Care Unit
Medical Center of Central Georgia Neonatal Intensive Care Unit The Effect of Music Therapy as a Nursing Intervention for the Inconsolable 32-40 Week Critically Ill Infant Dr. Douglas Keith, PhD, MT-BC
More informationNeonatal Reference Guide
Operated by REACH Air Medical Services Assessment Heart Rate (beats/min.) Age Rate
More informationObjectives. Objectives, continued 9/22/2015
Neonatal Abstinence Syndrome Jennifer Manning, DO Neonatologist, Akron Children s Hospital Mahoning Valley Clinical Associate Professor of Pediatrics, NEOMED September 27, 2015 Adapted from a lecture by
More informationStandard of Care: Neonatal Intensive Care Unit (NICU) Physical and Occupational Therapy Management of the high risk infant.
BRIGHAM & WOMEN S HOSPITAL Department of Rehabilitation Services Standard of Care: Neonatal Intensive Care Unit (NICU) Case Type / Diagnosis: The high-risk infant is defined as the baby with any event
More information2013 Transforming Neonatal Drug Withdrawal
2013 Transforming Neonatal Drug Withdrawal Carl R. Backes, DO Director, Neonatal Abstinence Clinic Nationwide Children s Hospital Clinical Assistant Professor, The Ohio State University There is a Problem
More informationManagement of Pregnancy. Opioid Addiction Treatment
Management of Pregnancy Opioid Addiction Treatment Perinatal Opioid Addiction Pharmacotherapy and co-ordination of care are essential elements in the comprehensive care of pregnant patients with opioid
More informationObjectives. What is NAS? What is NAS? Faculty Disclosure. Providing Optimal Care for Neonates with Neonatal Abstinence Syndrome
Providing Optimal Care for Neonates with Neonatal Abstinence Syndrome by Karen D Apolito, Ph.D., APRN, NNP-BC, FAAN Professor & Program Director, NNP Specialty Vanderbilt University School of Nursing This
More informationAssessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal
Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Roger Cicala, M. D. Assistant Medical Director Tennessee Physician s Wellness Program Step 1 Don t 1 It is legal in
More informationNaloxone Hydrochloride Injection PRODUCT INFORMATION
Naloxone Hydrochloride Injection PRODUCT INFORMATION DESCRIPTION Naloxone hydrochloride is 17-allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride; C 19 H 21 NO 4.HCl. It is an off-white powder
More informationObstetrical Emergencies
Date: July 18, 2014 Page 1 of 5 Obstetrical Emergencies Purpose: To provide the process for the assessment and management of the patient with an obstetrical related emergency. Pre-Medical Control 1. Follow
More informationManagement of Neonatal Opioid Withdrawal
Management of Neonatal Opioid Withdrawal Neonatal Abstinence Syndrome Overview... 1 Opioid Addiction... 1 Opioids and Pregnancy... 1 GUIDELINES FOR MANAGEMENT OF OPIOID-EXPOSED NEWBORNS... 3 Site of Care
More informationBREASTFEEDING; HOW? January 14 HELEN BORG, INFANT FEEDING MIDWIFE MATER DEI HOSPITAL
BREASTFEEDING; HOW? January 14 HELEN BORG, INFANT FEEDING MIDWIFE MATER DEI HOSPITAL 1 THE IMMIGRANT MOTHER- BABY DYAD Challenges to Breastfeeding and Bonding Lack of Information How to enhance milk supply
More informationFinnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5 6 in non-addicted infantsadd_2802 524..528
RESEARCH REPORT doi:1.1111/j.136-3.9.8.x Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5 6 in non-addicted infantsadd_8 5..58 Urs Zimmermann-Baer 1,, Ursula Nötzli
More informationCould you care for a baby withdrawing from drugs and/or alcohol? Family Futures Practice Paper Series
Could you care for a baby withdrawing from drugs and/or alcohol? Family Futures Practice Paper Series To promote the attachment that is vital for their healthy development a drug or alcohol addicted baby
More informationHow To Treat An Alcoholic Patient
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 Discontinue all lorazepam
More informationNALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT
NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT Opioid dependence is a devastating and frequently fatal medical condition. It is a manifestation of addictive disorder
More informationPremature Infant Care
Premature Infant Care Introduction A premature baby is born before the 37th week of pregnancy. Premature babies are also called preemies. Premature babies may have health problems because their organs
More informationOpiate treatment for opiate withdrawal in newborn infants (Review)
(Review) Osborn DA, Jeffery HE, Cole MJ This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2010, Issue 10 http://www.thecochranelibrary.com
More informationSubstance Abuse lifestyle Concern for mother - fetus - and - neonate
OBJECTIVES Learn about types of opioids and associated withdrawal symptoms Learn what medications are available to treat opioid addiction Understand the pros and cons associated with each medication Understand
More informationAdjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.
Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,
More informationGeneral PROVIDER INITIALS: PHYSICIAN ORDERS
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 General Vital Signs
More informationINTOXICATED PATIENTS AND DETOXIFICATION
VAMC Detoxification Decision Tree Updated May 2006 INTOXICATED PATIENTS AND DETOXIFICATION Patients often present for evaluation of substance use and possible detoxification. There are certain decisions
More informationPEDIATRIC AGE SPECIFIC
A Health System PEDIATRIC AGE SPECIFIC Self Learning Module For Clinical Staff Revised 6/10 Theresa Kirkpatrick, RN, MSN, CCRN, CPNP Kateri Tobias, RN, BSN Pediatric Age Specific Self Learning Module Instructions:
More information10/18/2012. The Impact of Substance Use on Newborns. Objectives. Do Infants Exposed to Maternal Opioids Have Drug Addiction?
Objectives The Impact of Substance Use on Newborns Pamela Harris-Haman, CRNP, NNP-BC 1. Discuss the incidence of drug use in pregnancy and the percentage of infants that have abstinence syndrome. 2. Review
More informationIncidence. Substance Abuse. Care of the Drug Exposed Infant. 2010 National Survey on Drug Use and Health:
Care of the Drug Exposed Infant Connie Anderson M.D. Assistant Professor of Pediatrics Saint Louis University School of Medicine Cardinal Glennon Children s Medical Center September 19,2012 Substance Abuse
More informationREFERENCE. Admit to: Program/Service: Diagnosis: Droplet/ Contact Airborne/ Contact
Weight (kg) REFER TO THE ALLERGY SCREEN IN MEDITECH FOR ALLERGY INFORMATION To complete the order form, fill in the required blanks and/or check the appropriate boxes. To delete orders, draw one line through
More informationUpstate University Health System Medication Exam - Version A
Upstate University Health System Medication Exam - Version A Name: ID Number: Date: Unit: Directions: Please read each question below. Choose the best response for each of the Multiple Choice and Medication
More informationSymptom Based Alcohol Withdrawal Treatment
Symptom Based Alcohol Withdrawal Treatment -Small Rural Hospital- Presenter CDR Dwight Humpherys, DO dwight.humpherys@ihs.gov Idaho State University Baccalaureate Nursing Program Lake Erie College of Osteopathic
More informationMethadone dosage for prevention of opioid withdrawal in children
Paediatric Anaesthesia 2003 13: 805 810 Methadone dosage for prevention of opioid withdrawal in children RAJASHEKHAR SIDDAPPA MD*, JAMES E. FLETCHER MBBS, ANDREW M.B. HEARD MBChB, DONNA KIELMA RN, MICHAEL
More informationNeonatal Reference Guide
Operated by REACH Air Medical Services Assessment Heart Rate (beats/min.) Rate
More informationOpiate Treatment for Aboriginal High School Students in Ontario
Opiate Treatment for Aboriginal High School Students in Ontario January 2014 1 CHALLENGE About 40% of the students at an Aboriginal high school in Thunder Bay Ontario (Canada) are known to be addicted
More informationMANAGEMENT OF THE INFANT BORN TO THE DRUG-ABUSING MOTHER Version: 5 Ratification Date: Feb 2014 Review Date: Feb 2017 Approval:
Title: MANAGEMENT OF THE INFANT BORN TO THE DRUG-ABUSING MOTHER Version: 5 Ratification Date: Feb 2014 Review Date: Feb 2017 Approval: Nottingham Neonatal Service Clinical Guideline Meeting Author: Sara
More informationChild Life Council 26 th Annual Conference on Professional Issues
Child Life Council 26 th Annual Conference on Professional Issues 47. Can You Hear Me Now? Reading Cues for Successful Infant Care Presented By: Erin Shipp, CCLS, CIMI, CPST, Child Life Specialist, Children's
More informationReview of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
More informationNICU Information Guide
NICU Information Guide A guide to understanding your baby s care and experience with The Medical Center Neonatal Intensive Care Unit (NICU) This book belongs to: My Baby is in the NICU, Now What? As a
More informationNURSING SERVICES DEPARTMENT
NURSING SERVICES DEPARTMENT TITLE: Mechanical Ventilation PATIENT CARE PLAN DIAGNOSIS: DISCHARGE CRITERIA: 1 The patient will: Maintain adequate mechanics of PERTINENT INFORMATION:. ventilation as demonstrated
More informationMagee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
More informationV11.2 NPIC/QAS. Special Quarterly Report: Linked Analysis Neonatal Abstinence Syndrome
V11.2 NPIC/QAS Special Quarterly Report: Linked Analysis Neonatal Abstinence Syndrome I. Background The use of drugs and alcohol during pregnancy has been shown in several studies to affect the health
More informationMEDICATION GUIDE. What is Morphine Sulfate Oral Solution?
MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and
More informationDISCHARGE CRITERIA FOR PHASE I & II- POST ANESTHESIA CARE
REFERENCES: The Joint Commission Accreditation Manual for Hospitals American Society of Post Anesthesia Nurses: Standards of Post Anesthesia Nursing Practice (1991, 2002). RELATED DOCUMENTS: SHC Administrative
More informationFrom the street to the NICU. Richard Christensen, PA, CAS
From the street to the NICU Richard Christensen, PA, CAS Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a stand-alone
More informationLike cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
More informationOpioid Treatment Agreement
Opioid Treatment Agreement 1. I understand that my provider and I will work together to find the most appropriate treatment for my chronic pain. I understand the goals of treatment are not to eliminate
More informationEstablished in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule
More informationPROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain
P a g e 1 PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain Clinical Phase 4 Study Centers Study Period 25 U.S. sites identified and reviewed by the Steering Committee and Contract
More informationNaltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance
Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance Introduction Indication/Licensing information: Naltrexone is licensed for use as an additional therapy, within
More informationParamedic Pediatric Medical Math Test
Paramedic Pediatric Medical Math Test Name: Date: Problem 1 Your 4 year old pediatric patient weighs 40 pounds. She is febrile. You need to administer acetaminophen (Tylenol) 15mg/kg. How many mg will
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationPackage leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride
A leaflet will be included in each pack. The leaflet will consist of a Technical Information Leaflet and a Patient Information Leaflet. The two leaflets will be easily separatable. The text of the Technical
More informationClonidine for Opioid Related Neonatal Abstinence Syndrome: Is Clonidine the New Alpha-Male of Adjunct?
Clonidine for Opioid Related Neonatal Abstinence Syndrome: Is Clonidine the New Alpha-Male of Adjunct? Learning Objectives Marc Flynt, PharmD Children s Hospital of San Antonio, San Antonio, TX Division
More information!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!
ADRENALINE IVI BOLUS IV Open a vial of 1:1000 ADRENALINE 1 mg /ml Add 1 ml to 9 ml N/Saline = 1mg adrenaline in 10 ml (or 100 mcg/ml) Add 1 ml 1:10,000 to 9 ml N/Saline = 100 mcg adrenaline in 10 ml (or
More informationAbstral Prescriber and Pharmacist Guide
Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of
More informationNeonatal Abstinence Syndrome: An Emerging Epidemic?
Neonatal Abstinence Syndrome: An Emerging Epidemic? March 11, 2013 Balaji Govindaswami, MD, MPH Chief Newborn Medicine, Director - NICU Santa Clara Valley Health and Hospital System, San Jose, CA Clinical
More informationBabies breaking bad: neonatal and iatrogenic withdrawal syndromes
REVIEW C URRENT OPINION Babies breaking bad: neonatal and iatrogenic withdrawal syndromes Rachel E.M. Cramton a,b and Nancy E. Gruchala a,b Purpose of review This review will summarize the symptoms, evaluation,
More informationMethadone and Pregnancy
Methadone and Pregnancy Methadone 101/Hospitalist Workshop Launette Rieb, MD, MSc, CCFP, CCSAM, FCFP Clinical Associate Professor, Dept. Family Practice, UBC American Board of Addiction Medicine Certified
More informationfor Management Guidelines Infants with Neonatal Abstinence Syndrome BACKGROUND DIFFERENTIAL DIAGNOSIS
Management Guidelines for Infants with Neonatal Abstinence Syndrome BACKGROUND Neonatal drug withdrawal can occur when newborn infants are exposed to medications or addictive substances in-utero, or can
More informationUsing the Brazelton Approach to Support Babies and Parents
Using the Brazelton Approach to Support Babies and Parents Megan Eccleson Infant Mental Health Specialist And Trainer for Brazelton Centre in Great Britain The Brazelton Centre is a charity whose primary
More informationCOMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE
COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE INTRODUCTION High dose sublingual buprenorphine (Subutex) tablets are available in the following strengths 0.4 mg, 2 mg, and 8 mg. Suboxone tablets,
More informationGuidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care
Hull & East Riding Prescribing Committee Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care 1. BACKGROUND Patients who are physically dependent
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationPHSW Procedural Sedation Post-Test Answer Key. For the following questions, circle the letter of the correct answer(s) or the word true or false.
PHSW Procedural Sedation Post-Test Answer Key 1 1. Define Procedural (Conscious) Sedation: A medically controlled state of depressed consciousness where the patient retains the ability to continuously
More informationMINI - COURSE On TEMPERATURE CONTROL IN THE NEWBORN
MINI - COURSE On TEMPERATURE CONTROL IN THE NEWBORN Instructions: Read each sheet and answer any questions as honestly as possible The first sheets have four questions to allow you to give your thoughts
More informationOpioid Analgesic Medication Information
Opioid Analgesic Medication Information This handout provides information about treating pain with opioid analgesics or narcotics. Please read this entire handout. We want to be sure that you understand
More informationAcute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC
Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635
More informationYour Baby s Care Team
UW MEDICINE PATIENT EDUCATION Your Baby s Care Team For parents of NICU infants Parents and Family You and your baby are the center of the NICU care team. As parents, you will give input and take part
More informationWhy is prematurity a concern?
Prematurity What is prematurity? A baby born before 37 weeks of pregnancy is considered premature. Approximately 12% of all babies are born prematurely. Terms that refer to premature babies are preterm
More information